Aptorum Group Ltd - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
APM Nasdaq 2834 http://www.aptorumgroup.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aptorum Group Ltd

Aptorum Group Limited's (NASDAQ:APM) Single Biggest Risk For Investors - Sep 19th, 2019 12:10 pm
Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma - Sep 9th, 2019 10:34 am
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2019 - Sep 9th, 2019 10:00 am
Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA - Sep 9th, 2019 10:00 am
APM: Aptorum Focused on Development of Diseases with Significant Global Unmet Needs - Jun 26th, 2019 3:05 pm
Aptorum Group to Be Newly Added to MSCI HK Micro Cap Index - May 22nd, 2019 12:00 pm
Aeneas Capital and Pyrinas Target Launch of US$120m Fund to Develop Co-Working Laboratory Ecosystems for Life Sciences Start-Ups in the United States - May 16th, 2019 1:00 am
What Percentage Of Aptorum Group Limited (NASDAQ:APM) Shares Do Insiders Own? - May 7th, 2019 11:19 am
Aptorum Group’s Subsidiary - Claves Life Sciences Limited Establishes Novel Therapeutic Platform for Treatment of Various Diseases via Modulation of the Chemical Signaling Relating to Gut Microbiota - May 6th, 2019 12:00 pm
UPDATE - Argus Research Initiates Equity Research Report Coverage on Aptorum Group Limited (NasdaqGM: APM) - Apr 30th, 2019 2:42 pm
USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations - Apr 24th, 2019 12:00 pm
Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™ - Apr 24th, 2019 8:30 am
Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases - Apr 24th, 2019 8:30 am
Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019 - Apr 24th, 2019 8:15 am
Aptorum Group Limited Reports 2018 Fiscal Year Financial Results and Business Update - Apr 15th, 2019 1:55 pm
Aptorum Group Limited Announces Appointment of Head of R&D and Chief Operating Officer - Apr 1st, 2019 1:30 pm
Aptorum Group Limited to Present at the Barclays Global Healthcare Conference 2019 - Mar 8th, 2019 7:49 pm